Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06293950
PHASE1

Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism

Sponsor: University of Jordan

View on ClinicalTrials.gov

Summary

Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities.

Key Details

Gender

All

Age Range

4 Years - 14 Years

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2022-03-09

Completion Date

2027-12

Last Updated

2025-01-24

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

WJMSC

\- Patients receive three intravenous doses of MSCs (1 million/kg) every two weeks as treatment.

Locations (1)

Cell Therapy Center

Amman, Jordan